论文部分内容阅读
应用ＡＰＡＣＨＥⅡ评分对我院ＳＩＣＵ１９９１年５月～１９９５年９月间连续的普外危重病１８２例严重度进行评估。用死亡率预测方程（ＭＰＭ）判定预后，结果显示平均ＡＰＡＣＨＥⅡ评分１８．２２±５．６分，预测病死率和实际病死率呈正相关（３１．３％ｖｓ３４．６％，γ＝０．９８），预测略低于实际（Ｐ＞０．０５）。２７例肝功能障碍者平均积分为２０．８±４．６分，预测病死率显著低于实际（３７．５％ｖｓ７０．４％，Ｐ＜０．００１）。为ＡＰＡＣＨＥⅡ预测意义的主要影响因素。入院时ＡＰＡＣＨＥⅡ＜１５分均存活，＞２８分均死亡，１５～２８分的共７２例，通过连续评分，于第５天或第２５天死亡组和存活组病人ＡＰＡＣＨＥⅡ出现显著性差异，有助于预后判断。监护技术的进步，会使病死率不断下降，ＡＰＡＣＨＥⅡ可作为评价ＳＩＣＵ救治水平的标尺。
Application of APACHE Ⅱ score on our hospital SICU May 1991 ~ September 1995 continuous serious generalized critical illness in 182 cases were evaluated. The prognosis was estimated by the mortality prediction equation (MPM). The mean APACHEⅡ score was 18.22 ± 5.6 and the predicted mortality was positively correlated with the actual mortality (31.3% vs 34.6%, γ = 0.98) , Slightly lower than the actual forecast (P> 0.05). The average score of 27 patients with liver dysfunction was 20.8 ± 4.6, the predicted mortality was significantly lower than the actual (37.5% vs 70.4%, P <0.001). The main influencing factors for APACHE Ⅱ prediction. APACHE Ⅱ <15 points survived at admission, died> 28 points, and 72 cases at 15-28 points. There was significant difference in APACHEⅡ between death group and survivor group on the 5th or 25th day by continuous score Judgment of prognosis. Monitoring technology advances, will make the case fatality rate decline, APACHE Ⅱ can be used as a measure of the level of SICU treatment.